In a post on LinkedIn, Hunter Walk, partner at Homebrew VC, talks the big reasons why venture capitalists aren’t always honest when they turn down a pitch. One of the main reasons: At the seed stage its 99 percent personal. Here are the three personal issues Walk points to that will cause VCs to back […]
Early stage medical device and biotech venture capitalist Mike Carusi with Advanced Technology Ventures (ATV) had a busy conference schedule at the J.P. Morgan Healthcare Conference in San Francisco earlier in January. What was different this year was the number of meetings the big “strategics” — the large medical device and pharmaceutical players — were willing to […]
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
For-profit biotech accelerator BioMotiv aims to shake up the early stage, drug discovery financing space. The Cleveland, Ohio company wants to invest in early stage drug discovery ideas but doesn’t want to deal with management. It wants to save a promising technology from the investment valley of death, but not the team. It does that […]